Metabolic health
Tirzepatide: Uses, Weight Management and Safety
Glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist; prescription medicine.
Overview
Tirzepatide is a peptide-based medicine that activates GIP and GLP-1 receptors. Different products containing tirzepatide have product-specific indications and labels.
How it works
It acts at GIP and GLP-1 receptors. The clinical role depends on the named product, the approved indication, and an individual clinician's assessment.
Uses described in the source
The current U.S. Zepbound label includes chronic weight management for eligible adults and treatment of moderate-to-severe obstructive sleep apnea in adults with obesity. Other tirzepatide products have different labels.
Evidence
Strong human evidence for product- and indication-specific FDA-labeled uses
Regulatory status
The cited Zepbound label is a U.S. FDA label for specified uses. It does not establish approval or availability in Colombia, or availability through YouMedicine.
Safety
The label includes a boxed warning about thyroid C-cell tumors observed in rats; human relevance is unknown. It contraindicates use for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Gastrointestinal effects and other warnings are described in the current product label.
YouMedicine availability
Educational listing only. YouMedicine availability has not been confirmed.
Sources
A product label is not an individual recommendation. Do not use this summary to choose a product, dose, or source; consult a licensed clinician and the current label.